Ra Medical Systems Announces Reverse Merger; Combined Company To Focus On Cardiac Arrhythmias
Ra Medical Systems Inc (NYSE:RMED) has agreed to merge with privately held Catheter Precision Inc, a medical device and technology company focused…
Why Is Clovis Oncology Stock Trading Higher Today?
Clovis Oncology Inc (NASDAQ: CLVS) shares are trading higher Monday after the company presented data showing Rubraca as a first-line maintenance treatment improved progression-free survival in advanced ovarian cancer.
HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here
Susquehanna cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $195. Susquehanna analyst Shyam Patil maintained the stock with a Positive rating. Baidu shares rose 0.7% to $139.38 in pre-market trading.
MariMed To Enter Missouri Cannabis Market
MariMed, Inc (OTCQX: MRMD) (CSE:MRMD) entered into an agreement that will bring the company’s portfolio of cannabis-infused edibles to Missouri. As part of the agreement, MariMed will develop and manage a production kitchen.
NuLeaf Naturals Launches Full Spectrum CBD & CBN Gummies
NuLeaf Naturals a subsidiary of High Tide Inc. (NASDAQ: HITI) launched a new line of products – gummies.
Akari Therapeutics Announced 15M ADS Registered Direct Offering Priced @$0.85/ADS
Akari Therapeutics, Plc (Nasdaq: AKTX) today announced it has entered into definitive agreements with healthcare-focused institutional investors alongside participation from certain existing investors, including the Akari Executive Chairman of the Board of Directors, Dr.
Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving Premarket
Gainers
Aditxt, Inc. (NASDAQ: ADTX) rose 46.1% to $0.2801 in pre-market trading after jumping 37% on Friday.
Ra Medical Systems Announced Definitive Merger Agreement with Catheter Precision; Merger Structured as Stock for Stock Reverse Merger
Ra Medical Systems, Inc. (NYSE American: RMED) ("Ra Medical" or the "Company") announces it has entered into an Agreement and Plan of Merger (the "Definitive Merger Agreement") with privately held Catheter Precision, Inc.
Adagene Announced Publication of Interim Monotherapy Data at ESMO 2022 Showing Compelling Safety, Anti-tumor Activity and Pharmacokinetics of Masked, Anti-CTLA-4 SAFEbody ADG126 in Patients With Advanced Tumors
Adagene Inc. ("Adagene") (Nasdaq: ADAG) today announced the publication of data showing the best-in-class potential of ADG126, a masked, anti-CTLA-4 SAFEbody®.
Oracle, JPMorgan And 3 Stocks To Watch Heading Into Monday
With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: